Home » BioReliance Announces Agreement With Barr to Supply Bulk Virus
BioReliance Announces Agreement With Barr to Supply Bulk Virus
BioReliance Corporation announced that it has been contracted by Barr Pharmaceuticals, Inc. to supply bulk adenovirus for the manufacture of Duramed Pharmaceuticals, Inc.’s Adenovirus Types 4 and 7 Live Oral Vaccines.
MarketWatch
MarketWatch
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May